Reviewed,
UniProtKB/Swiss-Prot P56636 (CXA2_CONMA)
Last modified
November 25, 2008.
Version 60.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Alpha-conotoxin MII Short name=CtxMII Short name=Alpha-MII Alternative name(s): Alpha-conotoxin M2 |
| Organism | Conus magus (Magus cone) (Magician's cone snail) |
| Taxonomic identifier | 6492 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Mollusca › Gastropoda › Orthogastropoda › Apogastropoda › Caenogastropoda › Sorbeoconcha › Hypsogastropoda › Neogastropoda › Conoidea › Conidae › Conus |
Protein attributes
| Sequence length | 68 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Alpha-conotoxins bind to the nicotinic acetylcholine receptors (nAChR) and inhibit them. This toxin blocks neuronal mammalian nAChRs (alpha-6 or -3/beta-2 or -3 > alpha-3/beta-2 > alpha-3/beta-4 = alpha-4/beta-2). |
| Subcellular location | |
| Tissue specificity | Expressed by the venom duct. |
| Miscellaneous | There are currently a number of patents describing the use of this peptide in therapeutic applications. |
| Sequence similarities | Belongs to the conotoxin A superfamily. Alpha-type family. |
| Mass spectrometry | Molecular weight is 1710.6 Da from positions 49 - 64. Determined by LSI. Ref.3 |
Ontologies
Keywords | |
|---|---|
| Cellular component | Secreted |
| Domain | Signal |
| Molecular function | Acetylcholine receptor inhibitor Neurotoxin Postsynaptic neurotoxin Toxin |
| PTM | Amidation |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | pathogenesis Inferred from electronic annotation. Source: InterPro synaptic transmissionInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | extracellular region Inferred from electronic annotation. Source: InterPro postsynaptic membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | acetylcholine receptor inhibitor activity Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||
Molecule processing | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | |||||||||||
| Propeptide | 22 – 48 | 27 | PRO_0000034881 | |||||||||||
| Peptide | 49 – 64 | 16 | Alpha-conotoxin MII | PRO_0000034882 | ||||||||||
Amino acid modifications | ||||||||||||||
| Modified residue | 64 | 1 | Cysteine amide | |||||||||||
| Disulfide bond | 50 ↔ 56 | |||||||||||||
| Disulfide bond | 51 ↔ 64 | |||||||||||||
Experimental info | ||||||||||||||
| Mutagenesis | 53 | 1 | N → A: Causes a >2700-fold reduction in activity at the alpha-3/beta-2 nAChR | |||||||||||
| Mutagenesis | 54 | 1 | P → A: Causes a 700-fold reduction in activity at the alpha-3/beta-2 nAChR | |||||||||||
| Mutagenesis | 57 | 1 | H → A: Causes a 17-fold reduction in activity at the alpha-3/beta-2 nAChR | |||||||||||
| Mutagenesis | 60 | 1 | H → A: Causes a 2700-fold reduction in activity at the alpha-3/beta-2 nAChR | |||||||||||
| Mutagenesis | 63 | 1 | L → A: Causes a 15-fold reduction in activity at the alpha-3/beta-2 nAChR | |||||||||||
Secondary structure | ||||||||||||||
Helix Strand Turn | ||||||||||||||
| Turn | 50 – 52 | 3 | ||||||||||||
| Helix | 55 – 59 | 5 | ||||||||||||
| Turn | 60 – 63 | 4 | ||||||||||||
Sequences
References
| [1] | "The A-superfamily of conotoxins: structural and functional divergence." Santos A.D., McIntosh J.M., Hillyard D.R., Cruz L.J., Olivera B.M. J. Biol. Chem. 279:17596-17606(2004) [PubMed: 14701840] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Venom duct. |
| [2] | "Alpha-conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors." McIntosh J.M., Dowell C., Watkins M., Garrett J.E., Yoshikami D., Olivera B.M. J. Biol. Chem. 277:33610-33615(2002) [PubMed: 12114524] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-68. Tissue: Hepatopancreas. |
| [3] | "A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors." Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. J. Biol. Chem. 271:7522-7528(1996) [PubMed: 8631783] [Abstract] Cited for: PROTEIN SEQUENCE OF 49-64, SYNTHESIS OF 49-64, AMIDATION AT CYS-64, DISULFIDE BONDS, MASS SPECTROMETRY, FUNCTION. Tissue: Venom. |
| [4] | "Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses." Kuryatov A., Olale F., Cooper J., Choi C., Lindstrom J. Neuropharmacology 39:2570-2590(2000) [PubMed: 11044728] [Abstract] Cited for: FUNCTION ON ALPHA-6 ACHR. |
| [5] | "Three-dimensional solution structure of alpha-conotoxin MII, an alpha3beta2 neuronal nicotinic acetylcholine receptor-targeted ligand." Shon K.-J., Koerber S.C., Rivier J.E., Olivera B.M., McIntosh J.M. Biochemistry 36:15693-15700(1997) [PubMed: 9398298] [Abstract] Cited for: STRUCTURE BY NMR OF 49-64, DISULFIDE BONDS. |
| [6] | "Three-dimensional solution structure of alpha-conotoxin MII by NMR spectroscopy: effects of solution environment on helicity." Hill J.M., Oomen C.J., Miranda L.P., Bingham J.-P., Alewood P.F., Craik D.J. Biochemistry 37:15621-15630(1998) [PubMed: 9843366] [Abstract] Cited for: STRUCTURE BY NMR OF 49-64, AMIDATION AT CYS-64, DISULFIDE BONDS. |
| [7] | "Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII." Clark R.J., Fischer H., Dempster L., Daly N.L., Rosengren K.J., Nevin S.T., Meunier F.A., Adams D.J., Craik D.J. Proc. Natl. Acad. Sci. U.S.A. 102:13767-13772(2005) [PubMed: 16162671] [Abstract] Cited for: CYCLIZATION, STRUCTURE BY NMR OF 49-64, DISULFIDE BONDS. |
| [8] | "Determinants of potency on alpha-conotoxin MII, a peptide antagonist of neuronal nicotinic receptors." Everhart D., Cartier G.E., Malhotra A., Gomes A.V., McIntosh J.M., Luetje C.W. Biochemistry 43:2732-2737(2004) [PubMed: 15005608] [Abstract] Cited for: MUTAGENESIS OF ASN-53; PRO-54; HIS-57; HIS-60 AND LEU-63. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIR | A59046. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR009958. Conotoxin_a-typ. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF07365. Toxin_8. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS60014. ALPHA_CONOTOXIN. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | CXA2_CONMA | ||||||||
| Accession | Primary (citable) accession number: P56636 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


